The last several weeks have seen several dramatic mergers of drug companies. Two experts talk about what these changes will mean for the industry, for stockholders, for drug research, and for consumers.

Guests

  • Wayne Pines consultant to the pharmaceutical industry
  • Dr. Sidney Wolfe director of the Health Research Group at Public Citizen; editor of WorstPills.org

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

“The Anatomy Of Love,” 25 Years Later

Thursday, Feb 11 2016In the early nineties, anthropologist Helen Fisher wrote “The Anatomy of Love: A Natural History of Mating, Marriage, and Why We Stray.” Now she’s back with the latest research on how love affects the brain and how the Internet has changed dating.

Erika Christakis: “The Importance Of Being Little”

Wednesday, Feb 10 2016Walk into a pre-school classroom in America today and Erika Christakis says it’s likely you’ll see some familiar décor: alphabet charts, bar graphs, calendars, and schedules. It’s all part, says the expert in early child education, of a nationwide drive to make sure kids are ready for school at a younger and younger age.

Analysis Of The New Hampshire Primary

Wednesday, Feb 10 2016New Hampshire holds the nation's first primary election. The winners, the losers and what the results could mean for the presidential candidates vying for the Democratic and Republican nominations.